Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Aug 15, 2023; 15(8): 1384-1399
Published online Aug 15, 2023. doi: 10.4251/wjgo.v15.i8.1384
Published online Aug 15, 2023. doi: 10.4251/wjgo.v15.i8.1384
Figure 2 miR-188-3p inhibition of gastric cancer cell growth and invasion.
A and B: 5-ethynyl-2-deoxyuridine (EdU) incorporation assay. AGS and BGC-823 cells were grown and transfected with miR-188-3p mimics, inhibitor, or their NC for 48 h. The EdU assay was then performed. The red fluorescence indicates EdU-positive cells, while the blue fluorescence indicates cell nuclei of all cells. The proliferation rate of tumor cells after transfection with miR-188-3p mimics was lower than that of tumor cells transfected with m-NC (cP < 0.001 vs m-NC or i-NC); C and D: Plate cloning assay. AGS and BGC-823 cells were transfected with miR-188-3p mimics, inhibitor, or their NC and then assayed using the plate-cloning assay. cP < 0.001.
- Citation: Lin JJ, Luo BH, Su T, Yang Q, Zhang QF, Dai WY, Liu Y, Xiang L. Antitumor activity of miR-188-3p in gastric cancer is achieved by targeting CBL expression and inactivating the AKT/mTOR signaling. World J Gastrointest Oncol 2023; 15(8): 1384-1399
- URL: https://www.wjgnet.com/1948-5204/full/v15/i8/1384.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i8.1384